Daré Bioscience closes $100K Reg A offering of 20,000 units at $5/unit

Dare Bioscience, Inc.

Issued 20,000 Investor Units, each: one share Series A Convertible Preferred + two warrants for common stock.
Gross proceeds of $100,000 from 20,000 units at $5.00 per unit.
Investor warrants exercisable for up to 40,000 shares of common stock.
Offering statement qualified by SEC on April 1, 2026; terms previously reported in Jan 29, 2026 8-K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.